Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
Other1.89B25.34%
Other products1.37B18.44%
Prolia999M13.41%
Enbrel567M7.61%
XGEVA561M7.53%
Repatha517M6.94%
TEPEZZA424M5.69%
Otezla394M5.29%
KYPROLIS376M5.05%
Aranesp349M4.69%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States19.81B70.26%
Rest of the world (ROW)8.38B29.74%